Research and experimental development on natural sciences and engineering
BRATBAK CONSULTING AS
Revenue 2025
NOK 307,000
Operating profit
NOK −279,000
Equity
NOK 4.2m
Incorporated
2019
Share capital
NOK 30,000
Roles
Daglig lederDaniel Fossum Bratbak
Regnskapsfører
Styrets lederDaniel Fossum Bratbak
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| MARIA GLORIA IRIARTE GARCIA | 50.0% | 1500.000000 | 2025 |
| DANIEL FOSSUM BRATBAK | 50.0% | 1500.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| KEIMON MEDICAL AS | Active | 72.0% | 7200.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.